Inventor
YAN XUELEI
US31 patents
⚠️ This page may combine multiple inventors who share the name “YAN XUELEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
15 patentsUS7524848B2Apr 28, 2009
Diaza heterocyclic amide compounds and their uses
AMGEN INC24 citations92
US9593129B2Mar 14, 2017
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC5 citations83
US9296736B2Mar 29, 2016
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC7 citations83
US9376425B2Jun 28, 2016
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC12 citations82
US11306107B2Apr 19, 2022
Compounds that inhibit MCL-1 protein
AMGEN INC2 citations71
US7402704B2Jul 22, 2008
Arylsulfones and uses related thereto
AMGEN INC3 citations62
US7605289B2Oct 20, 2009
Benzamide derivatives and uses related thereto
AMGEN INC4 citations60
US7659287B2Feb 9, 2010
Benzamide derivatives and uses related thereto
AMGEN INC1 citations52
US7834047B2Nov 16, 2010
Arylsulfonamides and uses related thereto
AMGEN INC0 citations51
US7754890B2Jul 13, 2010
Arylsulfones and uses related thereto
AMGEN INC0 citations51
US7495012B2Feb 24, 2009
Arylsulfonamides and uses related thereto
AMGEN INC0 citations51
US7365075B2Apr 29, 2008
Aryl sulfonamide compounds and uses related thereto
AMGEN INC1 citations51
US11407721B2Aug 9, 2022
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC0 citations50
US11274105B2Mar 15, 2022
Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonists
AMGEN INC0 citations48
US7825122B2Nov 2, 2010
Diaza heterocyclic sulfonamide derivatives and their uses
AMGEN INC0 citations41
ORIC PHARMACEUTICALS INC
6 patentsUS10472387B2Nov 12, 2019
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC2 citations73
US11124537B2Sep 21, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC1 citations61
US11208432B2Dec 28, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US11110103B2Sep 7, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US10836789B2Nov 17, 2020
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US10723759B2Jul 28, 2020
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
ARCUS BIOSCIENCES INC
6 patentsUS11787762B2Oct 17, 2023
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
ARCUS BIOSCIENCES INC2 citations69
US11407712B2Aug 9, 2022
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
ARCUS BIOSCIENCES INC3 citations69
US12103907B2Oct 1, 2024
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
ARCUS BIOSCIENCES INC0 citations59
US12384773B2Aug 12, 2025
Thiazole compounds and methods of use thereof
ARCUS BIOSCIENCES INC0 citations54
US12410170B2Sep 9, 2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds
ARCUS BIOSCIENCES INC0 citations48
US11931343B2Mar 19, 2024
CD73 inhibitors
ARCUS BIOSCIENCES INC0 citations48
POWERS JAY P
4 patentsUS8138190B2Mar 20, 2012
Diaza heterocyclic amide compounds and their uses
POWERS JAY P0 citations51
US8765788B2Jul 1, 2014
Tricyclic inhibitors of hydroxysteroid dehydrogenases
POWERS JAY P0 citations49
US8637576B2Jan 28, 2014
Benzamide derivatives and uses related thereto
POWERS JAY P0 citations48
US8772296B2Jul 8, 2014
Benzamide derivatives and uses related thereto
POWERS JAY P0 citations37